Non-peptide inhibitors of dpp iv and type ii diabetes

Objective

The inhibition of DPP IV is a validated target in anti-type II diabetic therapy. Existing inhibitors suffer from poor chemical stability or poor selectivity and will be optimised by substituting an amide group for a fluoroolefin group

Fields of science

• medical and health sciences › clinical medicine › endocrinology › diabetes

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-4. - Key action Environment and Health

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

UNIVERSITAIRE INSTELLING ANTWERPEN - UNIVERSITEIT ANTWERPEN

Address

Universiteitsplein 1
2610 Wilrijk (Antwerpen)
Belgium